VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment
Glioblastoma multiforme (GBM) is one of the most angiogenic tumors. However, antiangiogenic therapy has not shown significant clinical efficacy. The aim of our study was to evaluate the impact of inflammatory tumor microenvironment on the expression of vascular endothelial growth factor receptor 2 (...
Saved in:
Main Authors: | Jana Jaal, Marju Kase, Ave Minajeva, Mikk Saretok, Aidi Adamson, Jelizaveta Junninen, Tõnis Metsaots, Tõnu Jõgi, Madis Joonsalu, Markus Vardja, Toomas Asser |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | International Journal of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/385030 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small Cell Lung Cancer Patient with Profound Hyponatremia and Acute Neurological Symptoms: An Effective Treatment with Fludrocortisone
by: Jana Jaal, et al.
Published: (2015-01-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Glioblastoma Multiforme Stem Cells
by: Irena Dimov, et al.
Published: (2011-01-01) -
Gene Therapy for Glioblastoma Multiforme
by: Smit Shah, et al.
Published: (2025-01-01) -
Current Trends in Targeted Therapies for Glioblastoma Multiforme
by: Fumiharu Ohka, et al.
Published: (2012-01-01)